Annual Shareholders Equity
$12.05 M
-$15.88 M-56.85%
31 December 2023
Summary:
Evogene annual stockholders equity is currently $12.05 million, with the most recent change of -$15.88 million (-56.85%) on 31 December 2023. During the last 3 years, it has fallen by -$33.99 million (-73.82%). EVGN annual shareholders equity is now -90.34% below its all-time high of $124.75 million, reached on 31 December 2013.EVGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$4.34 M
-$7.41 M-241.60%
30 September 2024
Summary:
Evogene quarterly stockholders equity is currently -$4.34 million, with the most recent change of -$7.41 million (-241.60%) on 30 September 2024. Over the past year, it has dropped by -$22.85 million (-123.46%). EVGN quarterly shareholders equity is now -103.48% below its all-time high of $124.75 million, reached on 31 December 2013.EVGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.9% | -123.5% |
| 3 y3 years | -73.8% | -107.2% |
| 5 y5 years | -75.9% | -107.7% |
EVGN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -77.5% | at low | -107.2% | at low |
| 5 y | 5 years | -77.5% | at low | -106.1% | at low |
| alltime | all time | -90.3% | at low | -103.5% | at low |
Evogene Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$4.34 M(-241.6%) |
| June 2024 | - | $3.07 M(-63.0%) |
| Mar 2024 | - | $8.29 M(-31.2%) |
| Dec 2023 | $12.05 M(-56.8%) | $12.05 M(-34.9%) |
| Sept 2023 | - | $18.51 M(+29.5%) |
| June 2023 | - | $14.29 M(-35.3%) |
| Mar 2023 | - | $22.09 M(-20.9%) |
| Dec 2022 | $27.93 M(-47.9%) | $27.93 M(-8.7%) |
| Sept 2022 | - | $30.58 M(-17.2%) |
| June 2022 | - | $36.95 M(-18.8%) |
| Mar 2022 | - | $45.53 M(-15.1%) |
| Dec 2021 | $53.65 M(+16.5%) | $53.65 M(-11.6%) |
| Sept 2021 | - | $60.69 M(-8.6%) |
| June 2021 | - | $66.40 M(-7.2%) |
| Mar 2021 | - | $71.54 M(+55.4%) |
| Dec 2020 | $46.05 M(-8.2%) | $46.05 M(+2.5%) |
| Sept 2020 | - | $44.93 M(+13.0%) |
| June 2020 | - | $39.76 M(-9.6%) |
| Mar 2020 | - | $43.98 M(-12.3%) |
| Dec 2019 | $50.14 M(+0.2%) | $50.14 M(-10.6%) |
| Sept 2019 | - | $56.09 M(+31.7%) |
| June 2019 | - | $42.59 M(-8.5%) |
| Mar 2019 | - | $46.53 M(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $50.05 M(-27.9%) | $50.05 M(-9.8%) |
| Sept 2018 | - | $55.50 M(-7.4%) |
| June 2018 | - | $59.95 M(-6.8%) |
| Mar 2018 | - | $64.35 M(-7.3%) |
| Dec 2017 | $69.38 M(-20.5%) | $69.38 M(-7.5%) |
| Sept 2017 | - | $75.00 M(-5.5%) |
| June 2017 | - | $79.33 M(-4.8%) |
| Mar 2017 | - | $83.31 M(-4.6%) |
| Dec 2016 | $87.29 M(-15.9%) | $87.29 M(-6.4%) |
| Sept 2016 | - | $93.28 M(-4.5%) |
| June 2016 | - | $97.69 M(-3.6%) |
| Mar 2016 | - | $101.34 M(-2.3%) |
| Dec 2015 | $103.75 M(-10.6%) | $103.75 M(-4.0%) |
| Sept 2015 | - | $108.09 M(-2.1%) |
| June 2015 | - | $110.35 M(-2.9%) |
| Mar 2015 | - | $113.69 M(-2.1%) |
| Dec 2014 | $116.08 M(-6.9%) | $116.08 M(-3.5%) |
| Sept 2014 | - | $120.29 M(-1.3%) |
| June 2014 | - | $121.83 M(-1.7%) |
| Mar 2014 | - | $123.93 M(-0.7%) |
| Dec 2013 | $124.75 M(+158.5%) | $124.75 M(+168.8%) |
| Sept 2013 | - | $46.41 M(-1.9%) |
| June 2013 | - | $47.30 M(-2.0%) |
| Dec 2012 | $48.26 M | $48.26 M |
FAQ
- What is Evogene annual stockholders equity?
- What is the all time high annual shareholders equity for Evogene?
- What is Evogene annual shareholders equity year-on-year change?
- What is Evogene quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Evogene?
- What is Evogene quarterly shareholders equity year-on-year change?
What is Evogene annual stockholders equity?
The current annual shareholders equity of EVGN is $12.05 M
What is the all time high annual shareholders equity for Evogene?
Evogene all-time high annual stockholders equity is $124.75 M
What is Evogene annual shareholders equity year-on-year change?
Over the past year, EVGN annual stockholders equity has changed by -$15.88 M (-56.85%)
What is Evogene quarterly stockholders equity?
The current quarterly shareholders equity of EVGN is -$4.34 M
What is the all time high quarterly shareholders equity for Evogene?
Evogene all-time high quarterly stockholders equity is $124.75 M
What is Evogene quarterly shareholders equity year-on-year change?
Over the past year, EVGN quarterly stockholders equity has changed by -$22.85 M (-123.46%)